MedTrace Logo

Evaluating the Effects of Cleansers on the Skin

NCT03188653 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-06-04

No results posted yet for this study

Summary

This will be a single visit study that will take approximately 2 hours. Up to 50 subjects (up to 25 healthy subjects, and up to 25 subjects with AD) from BUMC dermatology clinics will be enrolled in this study and randomized to receive the 7 cleansers on 7 test spots on their upper extremities. One spot will serve as a control and not receive any cleanser. Each spot will be cleansed with the corresponding cleanser for 15 seconds then rinsed off with tap water. Skin barrier will be measured at baseline, immediately after, 30, 60 and 90 minutes after rinse off.

Conditions

Interventions

OTHER

CeraVe® Eczema Soothing Body Wash

One of the 7 arm locations will be selected to receive CeraVe® Eczema Soothing Body Wash

OTHER

Cetaphil® RestoraDerm® Eczema Calming Body Wash

One of the 7 arm locations will be selected to receive Cetaphil® RestoraDerm® Eczema Calming Body Wash

OTHER

Dove® Sensitive Skin Body Wash

One of the 7 arm locations will be selected to receive Dove® Sensitive Skin Body Wash

OTHER

Eucerin® Skin Calming Body Wash

One of the 7 arm locations will be selected to receive Eucerin® Skin Calming Body Wash

OTHER

Aveeno® Skin Relief Body Wash

One of the 7 arm locations will be selected to receive Aveeno® Skin Relief Body Wash

OTHER

MooGoo® Milk Wash

One of the 7 arm locations will be selected to receive MooGoo® Milk Wash

OTHER

Free & Clear Liquid Cleanser

One of the 7 arm locations will be selected to receive Free \& Clear Liquid Cleanser

Sponsors & Collaborators

  • University of Arizona

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-31
Primary Completion
2020-05-31
Completion
2020-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03188653 on ClinicalTrials.gov